Latest Breaking News On - Clin nephrol - Page 1 : comparemela.com

Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis

Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGlennm chertowLori hartwellJohnp butlerClin nephrolDivision of nephrology at stanford universityRenal support networkDrug administrationNational institutes of healthNational institute of diabetesExchange commissionAkebia therapeutics incClin lab haematolSteering committeeCompany to host conference call on

Vafseo® approved by the U S FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients

/PRNewswire/ CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved.

United statesThomas hutterGlennm chertowClin nephrolSteering committeeDrug administrationFresenius medical careVifor internationalAkebia therapeutics incNational institute of diabetesClin lab haematolNational institutes of healthDivision of nephrology at stanford universityAkebia therapeuticsGeneral managerStanford university

China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)

China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Macau generalMeixiang chenClin nephrolUrol nephrolChina medical system holdings limitedKidney international supplementsWinhealth investment hk limitedNational medical products administrationChina medical system holdings ltdConference of chinese nephrologist associationVifor fresenius medical care renal pharma ltdMedical system holdings limitedNovation agreementVifor fresenius medical care renal pharmaWinhealth investmentLicense agreement

China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro®

China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Macau generalMeixiang chenUrol nephrolClin nephrolKidney international supplementsInternational urologyNational medical products administrationWinhealth investment hk limitedConference of chinese nephrologist associationChina medical system holdings ltdVifor fresenius medical care renal pharma ltdNational reimbursement drug listChina medical system holdings limitedMedical system holdings limitedNovation agreementVifor fresenius medical care renal pharma

China Medical System (00867） Obtained Exclusive License of

SHENZHEN, CHINA, Feb. 03, 2024 (GLOBE NEWSWIRE) China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 2 February.

Macau generalUrol nephrolClin nephrolMeixiang chenKidney international supplementsChina medical system holdings limitedChina medical system holdings ltdInternational urologyVifor fresenius medical care renal pharma ltdNational reimbursement drug listWinhealth investment hk limitedNational medical products administrationConference of chinese nephrologist associationMedical system holdings limitedNovation agreementVifor fresenius medical care renal pharma